Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 AUD | 0.00% | -5.88% | -71.43% |
05-24 | Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial | MT |
05-23 | Adherium Raises Nearly AU$7 Million from Entitlement Offer | MT |
Sales 2022 | 529K 350K 480K | Sales 2023 | 3.2M 2.11M 2.9M | Capitalization | 12.5M 8.27M 11.34M |
---|---|---|---|---|---|
Net income 2022 | -10M -6.61M -9.08M | Net income 2023 | -9M -5.95M -8.17M | EV / Sales 2022 | 19.4 x |
Net cash position 2022 | 5.2M 3.44M 4.72M | Net cash position 2023 | 9.03M 5.97M 8.2M | EV / Sales 2023 | 1.08 x |
P/E ratio 2022 |
-1.4
x | P/E ratio 2023 |
-1.04
x | Employees | 40 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.99% |
1 week | -5.88% | ||
1 month | -15.79% | ||
3 months | -60.98% | ||
6 months | -48.39% | ||
Current year | -71.43% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Kaplon
DFI | Director of Finance/CFO | - | 22-10-09 |
Geoff Feakes
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-02 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 15-04-16 | |
Bill Hunter
BRD | Director/Board Member | 61 | 15-12-16 |
Bruce McHarrie
BRD | Director/Board Member | 66 | 15-07-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 0.016 | 0.00% | 1,300,337 |
24-06-13 | 0.016 | -5.88% | 50,000 |
24-06-12 | 0.017 | 0.00% | 88,999 |
24-06-11 | 0.017 | 0.00% | 313,668 |
24-06-07 | 0.017 | +6.25% | 100,429 |
Delayed Quote Australian S.E., June 14, 2024 at 01:21 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-71.43% | 7.72M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- ADR Stock